Skip to main content
Explore URMC

menu

Ovarian Cancer: Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Research Question:
Can the blood test, CA-125 be helpful in the early detection of ovarian cancer in women who are at low risk?

Basic Study Information

Purpose:
You will have blood drawn for the CA-125 testing and other tumor markers, depending on your CA-125 level, you will return and have blood drawn in 1 year or in 3 months or in 6 weeks plus a transvaginal ultrasound.

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT00539162?term=ID01-022&rank=1
Study Reference #: UGYO17017

Lead Researcher (Principal Investigator)

Lead Researcher: Richard Moore

Study Contact Information

Study Coordinator: Laura Mitchell
Phone: (585) 275-7763
Email: Laura_Mitchell@URMC.Rochester.edu

Additional Study Details

Return to Search